FDA launches safety review of RSV infant drugs as RFK Jr. scrutinizes immunizations
No safety issues have been reported for either product, drugmakers say.
5 across the spectrum · tap a section to jump
The story so far
2 developments- Dec 9, 2025FDA launches safety review of RSV infant drugs as RFK Jr. scrutinizes immunizations
- Dec 10, 2025US FDA launches fresh safety scrutiny of approved RSV therapies for infants
Who covered each development
No new developments
Quiet for 293 daysLast development · Dec 10, 2025 — US FDA launches fresh safety scrutiny of approved RSV therapies for infants
Left
3 viewpointsFDA opens safety review of injectable RSV drugs approved for babies and toddlers
FDA launches safety review of two RSV drugs for infants as Kennedy scrutinizes immunizations
Center
2 viewpointsRight
0 viewpointsSame wire story as other lanes. No original Right take here.
FDA opens safety review of injectable RSV drugs approved for babies and toddlers
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleUS health officials re-examine RSV shots despite documented safety and efficacy
Center
0 articlesNone
Right
0 articlesNone